Jaime Almandoz, M.D. Titles and Appointments Associate Professor School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Jaime Almandoz, M.D., M.B.A., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Endocrinology who serves as Medical Director of the Weight Wellness Program. His clinical and research interests include interdisciplinary weight management programs, post-bariatric weight recurrence and long-term outcomes, disparities in obesity care and access to evidence-based treatments, and cardiometabolic health and obesity-related complications. Originally from Trinidad, Dr. Almandoz received his medical degree from the Royal College of Surgeons in Ireland, where he graduated first in his class. He completed internal medicine residency training at the Mater Misericordiae Hospital in Dublin, and fellowship training in endocrinology, diabetes, metabolism, and nutrition at the Mayo Clinic in Rochester, Minnesota. He then completed an additional fellowship program in nutrition and metabolic diseases at UT Southwestern. He also holds a master's degree in healthcare management from UT Dallas and UT Southwestern. Certified by the American Board of Internal Medicine in internal medicine and a diplomate of the American Board of Obesity Medicine, Dr. Almandoz joined the UT Southwestern faculty in 2013. A nationally recognized leader in obesity medicine, Dr. Almandoz serves on the board of directors for the American Board of Obesity Medicine (ABOM) and as Vice Chair of the Nutrition and Obesity Disease State Network for the American Association of Clinical Endocrinology (AACE). He has also served on the governing board of The Obesity Society and is involved with a variety of other professional organizations, including the Endocrine Society and American Diabetes Association. Dr. Almandoz publishes the results of his work frequently in top-tier obesity and endocrinology journals and is frequently invited to speak at national and international conferences on obesity management. Education Medical School Royal College of Surgeons in Ireland (2004) Internship Beaumont Hospital (2005), Internal Medicine Residency Mater Misericordiae University Hospital (2007), Internal Medicine Residency Mayo Clinic College of Medicine and Science (2009), Internal Medicine Fellowship Mayo Clinic College of Medicine and Science (2012), Endocrinology, Diabetes, Metabolism & Nutrition Fellowship UT Southwestern Medical Center (2013), Nutrition & Metabolic Diseases Research Interest Effects of weight loss on metabolism Metabolic complications of obesity Post-bariatric care Weight Management Publications Featured Publications Substance Use, Mental Health, and Weight-Related Behaviors During the COVID-19 Pandemic Among Metabolic and Bariatric Surgery Patients. Messiah SE, Uppuluri M, Xie L, Schellinger JN, Mathew MS, Ofori A, Kukreja S, Schneider B, Dunn SH, Tavakkoli A, Almandoz JP, Obes Surg 2021 May Pharmacotherapies for Post-Bariatric Weight Regain: Real-World Comparative Outcomes. Gazda CL, Clark JD, Lingvay I, Almandoz JP, Obesity (Silver Spring) 2021 05 29 5 829-836 Telehealth utilization among multi-ethnic patients with obesity during the COVID-19 pandemic. Almandoz JP, Xie L, Schellinger JN, Mathew MS, Edwards K, Ofori A, Kukreja S, Schneider B, Messiah SE, J Telemed Telecare 2021 Mar 1357633X21998211 Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance. Almandoz JP, Lingvay I, Morales J, Campos C, Clin Diabetes 2020 Oct 38 4 390-402 Impact of COVID-19 Stay-at-Home Orders on Weight-Related Behaviors Among Patients with Obesity. Almandoz JP, Xie L, Schellinger JN, Mathew MS, Gazda C, Ofori A, Kukreja S, Messiah SE, Clin Obes 2020 Jun e12386 Sleeve Gastrectomy for Weight Loss. Puzziferri N, Almandoz JP JAMA 2018 01 319 3 316 Immunosuppression and Clostridium difficile Infection Risk in Metabolic and Bariatric Surgery Patients. Morales-Marroquin E, Xie L, Uppuluri M, Almandoz JP, Cruz-Muñoz N, Messiah SE, J Am Coll Surg 2021 May Type 2 Diabetes and HbA1c Predict All-Cause Post-Metabolic and Bariatric Surgery Hospital Readmission. Morales-Marroquin E, Xie L, Meneghini L, de la Cruz-Muñoz N, Almandoz JP, Mathew SM, Schneider BE, Messiah SE, Obesity (Silver Spring) 2021 01 29 1 71-78 Impact of bariatric surgery on cerebral vascular reactivity and cognitive function: a non-randomized pilot study. Tucker WJ, Thomas BP, Puzziferri N, Samuel TJ, Zaha VG, Lingvay I, Almandoz J, Wang J, Gonzales EA, Brothers RM, Nelson MD, Pilot Feasibility Stud 2020 6 21 Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy. Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N Diabetes Metab Syndr Obes 2017 10 393-402 Results 1-10 of 16 1 2 Next Last Books Featured Books Obesity Management and Prevention of Cardiovascular Disease. In ASPC Manual of Preventive Cardiology C Gazda, JP Almandoz (2021). Springer Honors & Awards Captain Massey-Miles Prize in Obstetrics & GynecologyMedical School Graduation (2004) Mahon Medal in MedicineMedical School Graduation (2004) Rueben Harvey Prize from the Royal College of Physicians and Surgeons, Dublin, IrelandGraduating first in medical school class (2004) Wheeler Medal in SurgeryMedical School Graduation (2004) Professional Associations/Affiliations American Diabetes Association (2012) The Obesity Society (2013)
